Review on epigenetics in cancer gene therapy: Series I

Cancer Gene Therapy

Volumn 12, Issue 8, 2005, Pages 663-664

  El Osta, Assam ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A; ZINC FINGER PROTEIN;

CANCER CELL; CANCER GENETICS; CANCER THERAPY; CHROMATIN STRUCTURE; CLINICAL TRIAL; CPG ISLAND; DNA METHYLATION; EDITORIAL; EPIGENETICS; GENE ACTIVATION; GENE REPRESSION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENOME; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; ZINC FINGER MOTIF;

EID: 22944446819     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700884     Document Type: Editorial

References (18)

1. Schmid M, Haaf T, Grunert D. 5-Azacytidine-induced undercondensations in human chromosomes. Hum Genet. 1984;67:257-263.
2. Toth KF, Knoch TA, Wachsmuth M, et al. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. J Cell Sci. 2004;117(Part 18):4277-4287.
3. Gius D, Cui H, Bradbury CM, et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell. 2004;6:361-371.
4. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999;21:103-107.
5. Nguyen CT, Weisenberger DJ, Velicescu M, et al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 2002;62:6456-6461.
6. El-Osta A, Kantharidis P, Zalcberg JR, Wolffe AP. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol Cell Biol. 2002;22:1844-1857.
7. Danam RP, Howell SR, Brent TP, Harris LC. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Mol Cancer Ther. 2005;4:61-69.
8. Magdinier F, Wolffe AP. Selective association of the methyl-CpG binding protein MBD2 with the silent p 14/ pi6 locus in human neoplasia. Proc Natl Acad Sci USA. 2001;98:4990-4995.
9. Ballestar E, Paz MF, Valle L, et al. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 2003;22:6335-6345.
10. Snowden AW, Gregory PD, Case CC, Pabo CO. Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr Biol. 2002;12:2159-2166.
11. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042-2054.
12. Motiwala T, Ghoshal K, Das A, et al. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogens. 2003;22:6319-6331.
13. Motiwala T, Kutay H, Ghoshal K, et al. Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci USA. 2004;101:13844-13849.
14. Lippman Z, Martienssen R. The role of RNA interference in heterochromatic silencing. Nature. 2004;431:364-370.
15. Verdel A, Jia S, Gerber S, et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Science. 2004; 303:672-676.
16. Zilberman D, Cao X, Johansen LK, Xie Z, Carrington JC, Jacobsen SE. Role of Arabidopsis ARGONAUTE4 in RNA-directed DNA methylation triggered by inverted repeats. Curr Biol. 2004;14:1214-1220.
17. Kawasaki H, Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature. 2004;431:211-217.
18. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science. 2004;305:1289-1292.